acetylshikonin has been researched along with Lymphoma, Large B-Cell, Diffuse in 1 studies
*Lymphoma, Large B-Cell, Diffuse: Malignant lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, J; Guo, R; Li, H; Li, J; Song, X; Song, Y; Wang, Y | 1 |
1 other study(ies) available for acetylshikonin and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
Acetylshikonin suppresses diffuse large B-Cell Lymphoma cell growth by targeting the T-lymphokine-activated killer cell-originated protein kinase signalling pathway.
Topics: Animals; Anthraquinones; Cell Line, Tumor; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Lymphoid Tissue; Lymphoma, Large B-Cell, Diffuse; Mice; Mice, Nude; Middle Aged; Mitogen-Activated Protein Kinase Kinases; Signal Transduction; Xenograft Model Antitumor Assays | 2022 |